There was a mistake in Figures 1–3 as published. The figures were placed in the wrong order in the text. The corrected Figures 1–3 appears below.
FIGURE 1
FIGURE 2
FIGURE 3
There was a mistake in the caption of Figure 2 as published. The corrected caption of Figure 2 appears below.
There was a mistake in the caption of Figure 3 as published. The corrected caption of Figure 3 appears below.
There was a mistake in the caption of Figure 4 as published. The corrected caption of Figure 4 appears below.
FIGURE 4
A correction has been made to the section Results, Sub Section “Glycocalyx Damage Parameters during NMP”, Subsub Section “Heparan Sulfate”, Paragraph “1”. The Sentence: “No significant dynamics of heparan sulfate were observed during NMP (p = 0.100) (Figure 4)” has been changed to: “No significant dynamics of heparan sulfate were observed during NMP (p = 0.100) (Figure 2).”
A correction has been made to the section Section “Results”, Sub Section “Outcome Associations of Glycocalyx Injury During NMP”, Paragraph “1”. The Sentence: “Furthermore, perfusate syndecan-1 values where significantly higher in grafts of recipients who developed EAD (n = 10) compared to those without EAD (n = 11) (4,331.5 (4,180.3–5,033.7) ng/mL vs. 2,800.7 (2,480.5–3,618.7) ng/mL; p = 0.024 and 9,379.7 (6,181–104,923) ng/mL vs. 4,338.9 (3,730–6,201.3) ng/mL; p = 0.013 and 8,663.6 (6,926.2–11,551.9) ng/mL vs. 5,096.5 (3,795–5,679.5) ng/mL; p = 0.013) (Figure 2).” should be changed to: “Furthermore, perfusate syndecan-1 values where significantly higher in grafts of recipients who developed EAD (n = 10) compared to those without EAD (n = 11) (4,331.5 (4,180.3–5,033.7) ng/mL vs. 2,800.7 (2,480.5–3,618.7) ng/mL; p = 0.024 and 9,379.7 (6,181–104,923) ng/mL vs. 4,338.9 (3,730–6,201.3) ng/mL; p = 0.013 and 8,663.6 (6,926.2–11,551.9) ng/mL vs. 5,096.5 (3,795–5,679.5) ng/mL; p = 0.013) (Figure 3).”
A correction has been made to the section Section “Results”, Sub Section “Outcome Associations of Glycocalyx Injury During NMP”, Paragraph “2”. The Sentence: “Grafts that were classified as transplantable (n = 23) exhibited significantly lower syndecan-1 levels at the onset of perfusion (3,892.6 (2,883.7–4,561.2) ng/mL) and after six hours of perfusion (5,915.7 (4,082.2–9,379.7) ng/mL) when compared to grafts that were classified as unsuitable for transplantation due to their metabolic profile (5,653.7 (5,074–11,706.6) ng/mL; p = 0.001 and 7,764.8 (7,133.6–12,740.7) ng/mL; p = 0.037) (Figure 3).” should be changed to “Grafts that were classified as transplantable (n = 23) exhibited significantly lower syndecan-1 levels at the onset of perfusion (3,892.6 (2,883.7–4,561.2) ng/mL) and after six hours of perfusion (5,915.7 (4,082.2–9,379.7) ng/mL) when compared to grafts that were classified as unsuitable for transplantation due to their metabolic profile (5,653.7 (5,074–11,706.6) ng/mL; p = 0.001 and 7,764.8 (7,133.6–12,740.7) ng/mL; p = 0.037) (Figure 4).”
A correction has been made to the section Section “Results”, Sub Section “Glycocalyx Damage Parameters in the Recipient”, Paragraph “2”. The Sentence: “However, from postoperative day 1 to postoperative day 2 (24.3 (13.2–35.1) ng/mL; p = 0.006) and postoperative day 3 (18.7 (10.1–30.8) ng/mL; p = 0.008), heparan sulfate levels experienced a decrease, reaching values below the preoperative baseline (p = 0.006) (Figure 4).” should be changed to “However, from postoperative day 1 to postoperative day 2 (24.3 (13.2–35.1) ng/mL; p = 0.006) and postoperative day 3 (18.7 (10.1–30.8) ng/mL; p = 0.008), heparan sulfate levels experienced a decrease, reaching values below the preoperative baseline (p = 0.006) (Figure 2).”
The original article has been updated.
Generative AI statement
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Summary
Keywords
glycocalyx, heparan sulfate, liver transplantation, normothermic machine perfusion, syndecan-1
Citation
Mathis S, Putzer G, Gasteiger L, Staier N, Schlosser L, Tscholl P, Breitkopf R, Cardini B, Kofler A, Oberhuber R, Resch T, Schneeberger S and Martini J (2026) Correction: Effect of normothermic machine perfusion on glycocalyx shedding during liver transplantation - a prospective pilot study. Transpl. Int. 39:16694. doi: 10.3389/ti.2026.16694
Received
01 April 2026
Revised
02 April 2026
Accepted
23 April 2026
Published
06 May 2026
Volume
39 - 2026
Updates
Copyright
© 2026 Mathis, Putzer, Gasteiger, Staier, Schlosser, Tscholl, Breitkopf, Cardini, Kofler, Oberhuber, Resch, Schneeberger and Martini.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Judith Martini, judith.martini@i-med.ac.at
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.